Partial Versus Radical Nephrectomy: Complexity of Decision-Making and Utility of AUA Guidelines.


Journal

Clinical genitourinary cancer
ISSN: 1938-0682
Titre abrégé: Clin Genitourin Cancer
Pays: United States
ID NLM: 101260955

Informations de publication

Date de publication:
12 2022
Historique:
received: 09 02 2022
revised: 30 05 2022
accepted: 05 06 2022
pubmed: 2 7 2022
medline: 6 12 2022
entrez: 1 7 2022
Statut: ppublish

Résumé

The American-Urological-Association(AUA) Guidelines for renal cancer(2017) recommend consideration for radical-nephrectomy(RN) over partial(PN) whenever there is increased oncologic-risk; and RN should be prioritized if three other criteria are all also met: 1) increased tumor-complexity; 2) no preexisting chronic-kidney-disease/ proteinuria, and 3) normal contralateral kidney that will likely provide estimated glomerular-filtration-rate (eGFR) >45ml/min/1.73m Retrospective review of 267 consecutive RN/PN from 2019(100-RN/167-PN). High tumor-complexity was defined as R.E.N.A.L.≥9. Increased oncologic-risk was defined as tumor >7cm, locally-advanced or infiltrative-features on imaging, or high-risk pathology on biopsy, if obtained. New-baseline GFR after RN was estimated using global-GFR, split-renal-function 163 patients(61%) fit scenarios that are well-defined in the Guidelines. Of these, 34 had strong indications for RN, and all had RN. Twelve of 129 patients(9.3%) underwent RN despite Guidelines generally favoring PN. The remaining 104 patients(39%) did not fit within situations where the Guidelines provide specific recommendations. In these patients, RN was often performed despite functional-considerations favoring PN due to overriding concerns about oncologic-risk and/or tumor-complexity. Our data demonstrate complexity of decision-making about PN/RN as almost 40% of patients did not fit well-described AUA Guidelines descriptors. Compliance was generally strong although occasional overutilization of RN remains a concern in our series, and will be addressed with additional education. Further studies will be required to assess the generalizability of our findings in other institutions/settings.

Identifiants

pubmed: 35778335
pii: S1558-7673(22)00130-6
doi: 10.1016/j.clgc.2022.06.003
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

501-509

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Auteurs

Rebecca A Campbell (RA)

Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH.

Jason Scovell (J)

Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH.

Nityam Rathi (N)

Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH; Cleveland Clinic Lerner College of Medicine, Cleveland Clinic, Cleveland, OH.

Pedram Aram (P)

Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH.

Yosuke Yasuda (Y)

Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH.

Venkatesh Krishnamurthi (V)

Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH.

Mohamed Eltemamy (M)

Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH.

David Goldfarb (D)

Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH.

Alvin Wee (A)

Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH.

Jihad Kaouk (J)

Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH.

Christopher Weight (C)

Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH.

Georges-Pascal Haber (GP)

Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH.

Steven C Campbell (SC)

Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH. Electronic address: campbes3@ccf.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH